Agenda Details

As a follow on to the successful 2022 FDA/EMA regulator fireside chat, this symposium will bring together senior leaders from global health authorities to discuss important aspects of their regulatory frameworks for cell and gene therapy products. The firesid chat style-symposium will include discussion of the current outlook for cell and gene therapy development in 2023 and beyond. Speakers may address topics including upcoming guidance documents, new policies, and convergence efforts between regulatory bodies. The symposium will consist almost entirely of moderated discussion, with an opportunity for each participant to give a brief opening statement on the key points they wish to highlight.